Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of BBI608 (napabucasin) in Adult Patients With Advanced Solid Tumors
jRCT2080222106Phase 1
- Sponsor
- Sumitomo Pharma
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of napabucasin in Nonhematologic neoplasms, sponsored by Sumitomo Pharma.
02
Drugs
napabucasin
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080222106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222106.